Bypassing a molecular breakdown that helps trigger autoimmunity could lead to new treatments for autoimmune disorders and chronic infections that sicken or kill thousands of children annually, according to researchers. Scientists have discovered genetic evidence that two distinct molecular pathways control the formation of regulatory T cells, a vitally important cell type in limiting undesirable immune responses.